Sussex Formulary

Drug Status Key

  • Non-Specialist Drugs
  • Specialist recommendation (or initiation where noted)
  • Specialist Initiation WITH Shared Care Guidelines
  • Specialist ONLY Drugs
  • Mixed Status - See individual drug entries for more details

Preferences

  • First Line
  • Second Line
  • Third Line
  • No Preference

5.6.6 Influenza

Oseltamivir or zanamivir – can they be used in breastfeeding mothers for the treatment or prophylaxis of influenza? (SPS - Specialist Pharmacy Service)

Managing common infections: guidance for primary care (Gov.UK)

Guidance on the use of antiviral agents for the treatment and prophylaxis of seasonal influenza (publishing.service.gov.uk)

ANNUAL VACCINATION ESSENTIAL FOR THOSE AT RISK.

Oseltamivir

{ Value = MHRA Warning Exists, Index = 4 } { Value = NICE, Index = 0 } { Value = EMC, Index = 3 }

Endorse SLS when written on FP10.

Treatment and post exposure prophylaxis only. Not recommended for seasonal prophylaxis of influenza (for treatment and post exposure prophylaxis ONLY). NOTE: National guidance on flu jabs. For flu that is not a widespread epidemic: oseltamivir, zanamivir are recommended options in non-vaccinated, flu exposed, 'at risk' people in specified circumstances. Amantadine is not recommended to prevent flu.

Oral suspension reserved for children under 1 year. Children over one and adults with swallowing difficulties, should use capsules which are opened and mixed into an appropriate sugary liquid as oseltamivir has a very bitter taste.

Oseltamivir 30mg capsules

Pack
10 capsule

Oseltamivir 45mg capsules

Pack
10 capsule

Oseltamivir 75mg capsules

Pack
10 capsule

Oseltamivir 60mg/5ml oral suspension sugar free

Pack
75 ml

Zanamivir

{ Value = MHRA Warning Exists, Index = 4 } { Value = NICE, Index = 0 } { Value = EMC, Index = 3 }